Desflurane Patent Expiration

Desflurane was first introduced by Baxter Healthcare Corp in its drug Suprane on Sep 18, 1992. 2 different companies have introduced drugs containing Desflurane.


Desflurane Patents

Given below is the list of patents protecting Desflurane, along with the drug name that holds that patent and the company name owning that drug.

Drug Used in Drug Patent Number Drug Patent Title Drug Patent Expiry Drug Owner
Suprane US5617906

(Pediatric)

Container for anaesthetic agent Oct 08, 2014

(Expired)

Baxter Hlthcare
Suprane US5617906 Container for anaesthetic agent Apr 08, 2014

(Expired)

Baxter Hlthcare



Desflurane's Family Patents

Family Patents

Explore Our Curated Drug Screens

Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List

Desflurane Generic API Manufacturers

Only one generic application has been filed for Desflurane.

Given below is the list of companies who have filed for Desflurane generic, along with the locations of their manufacturing plants worldwide.


1. SHANGHAI HENGRUI

Shanghai Hengrui Pharmaceutical Co Ltd has filed for 1 generic for Desflurane. Given below are the details of the strengths of this generic introduced by Shanghai Hengrui.

Strength Dosage Form Availability Application Pathway TE code Launch Date
100%

liquid Prescription INHALATION AN Feb 26, 2018


Manufacturing Plant Locations
New

Shanghai Hengrui's manufacturing plants are situated in 1 country - China. Given below are the details of these plant locations as well as the firm names of Shanghai Hengrui as present at those locations.

Country City Firm Name
China
Shanghai Shanghai Hengrui Pharmaceutical